Goldman Sachs vs JPMorgan Chase GS vs JPM

Goldman Sachs and JPMorgan Chase on one sheet: valuation multiples, growth, margins, debt, dividends and returns, each section labelled with the period it covers, from the companies' filings. Add or remove a stock above the sheet; the link holds the set.

Compare other stocks

GSJPM

Often compared:+ MS + BAC + WFC

What differs most

generated from the numbers below

Market value: JPMorgan Chase $903.04B, Goldman Sachs $256.60B.
Debt / equity: Goldman Sachs 2.8×, JPMorgan Chase 1.2×.

Price return

2025-10-16 → 2026-10-16

GS+16.2%

JPM+13.8%

Prices at the close on 2026-10-16

Goldman Sachs

$881.26

JPM

JPMorgan Chase

$339.72

Profile

latest

Sector

Financial Services

Industry

Financial - Capital Markets

Banks - Diversified

Market value

$256.60B

$903.04B

Enterprise value

$417.29B

$1.05T

Employees

47,400

320,560

Revenue per employee (TTM)

—

Our models

nightlythe valuation on each stock's page

Price vs model

at model vs model

11% overvalued vs model

Model range

$831–1015

$267–356

Models in the headline

FCF growth priced in, at a 10% return

—

Every model, its assumptions and its range: GS valuation · JPM valuation. The growth priced in, at any return: GS reverse DCF · JPM reverse DCF.

Trading

close 2026-10-16

Last close

$881.26

$339.72

52-week high

$1152.07

$365.18

52-week low

$744.60

$282.84

Price vs 52-week high

−23.5%

−7.0%

Price vs 52-week low

+18.4%

+20.1%

Average daily volume / shares

0.7%

0.3%

Beta

1.28

1.01

Returns

to 2026-10-16

1 month

−6.0%

−2.6%

3 months

−19.6%

−1.0%

6 months

−2.1%

+9.6%

Year to date

+0.3%

+5.4%

1 year

+16.2%

+13.8%

1 year, dividends added

+18.6%

+15.9%

2 years

+66.3%

+51.9%

Valuation

price × TTM to Jun 2026

P/E (TTM)

13.6×

14.5×

P/E on consensus EPS (next FY)

12.8×

13.7×

Price / sales

—

EV / sales

—

EV / EBITDA

—

Price / book

2.1×

2.4×

Price / free cash flow (FY)

n/m

—

Free-cash-flow yield (FY)

−18.4%

—

Growth

TTM and FY2025

Revenue growth (TTM)

—

Revenue growth, consensus next FY

—

+14.3%

Revenue, 3-year CAGR

—

12.3%

Revenue, 5-year CAGR

—

8.8%

EPS growth (TTM)

—

EPS growth, consensus next FY

+33.9%

+23.9%

EPS, 3-year CAGR

19.5%

18.3%

Free cash flow, 3-year CAGR

—

Diluted shares, 3-year change

−11.3%

−6.3%

Profitability

TTM to Jun 2026

Gross margin (FY)†

47.5%

59.9%

Operating margin

—

EBITDA margin

—

Net margin

—

Free-cash-flow margin (FY)

—

Return on equity

17.1%

17.4%

Return on assets

1.0%

1.3%

Asset turnover

—

† Gross margin (FY): As filed. Companies draw the cost-of-revenue line in different places, so gross margins of two companies in one industry can differ for that reason alone; operating margin does not depend on where the line is drawn.

Balance sheet

MRQ Jun 2026

Cash

$187.27B

$309.81B

Total debt

$347.96B

$460.52B

Net debt

$160.70B

$150.71B

Debt / equity

2.8×

1.2×

Net debt / EBITDA (TTM)

—

Interest coverage (FY)

0.3×

0.7×

Current ratio (FY)

0.83

0.52

Dividends

trailing 12 months

Dividend yield

2.0%

1.8%

Dividends per share

$18.00

$6.15

Payout ratio (of TTM EPS)

27.8%

26.3%

Dividend per share, 5-year CAGR

25.6%

10.7%

Frequency

Quarterly

Ownership and activity

last 90 days · latest 13F

Tracked superinvestors holding (13F)

Insider open-market buys (Form 4)

Insider sales (Form 4)

$805K

$1.8M

Analyst upgrades

Analyst downgrades

Statements

income TTM to Jun 2026 · cash flow FY2025

Revenue

—

EBITDA

—

Operating income

—

Net income

$20.97B

$65.07B

EPS (diluted)

$64.82

$23.35

Operating cash flow

−$45.15B

−$147.78B

Capital expenditure

−$2.06B

—

Free cash flow

−$47.22B

—

Dividends paid

$5.28B

$16.63B

Keep comparing

the matchups people search for

Goldman Sachs against

GS vs MS

JPMorgan Chase against

BAC vs JPM JPM vs WFC

Every ready-made comparison →

Statements from the companies' SEC filings; prices, dividends and consensus estimates from Financial Modeling Prep; insider trades from Form 4 and holdings from 13F. Refreshed nightly. A comparison of filed numbers, not a recommendation to buy, sell or hold any security.